Loading
Latest filing published 03 Sept 2026 for BIOMERIEUX.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
François LACOSTE, listed as chief executive, appears in our data through filings on Biomerieux shares, published by AMF. The record holds 5 filings, for trades running from 26 February 2022 to 31 August 2026.
The open-market record is one-sided, with 4 purchases worth €2,000 and not one sale. No amount is published for 3 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant. Since January 2026: 1 purchase and no sales on the market.
The newest entry dates from 3 September 2026: an open-market purchase, in Biomerieux. The median gap between a trade and its publication by AMF is 11 days. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from AMF disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 of 5 declarations